The current guidelines for post-curative treatment monitoring of CRC rely on a serial blood biomarker known as CEA (carcinoembryonic antigen) and CT imaging. Despite CEA testing being standard of ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

The increases were even higher in individuals over 60, those with preexisting conditions such as diabetes or heart disease, and patients with elevated levels of carcinoembryonic antigen (CEA), a ...

The study focused on developing highly sensitive sensors for two key lung cancer biomarkers: neuron-specific enolase (NSE) and carcinoembryonic antigen (CEA). The sensors were tested with buffer ...

such as bile cytology and bile carcinoembryonic antigen (CEA) levels, and dual phase CT or magnetic resonance (MR) sequences should be obtained before a confident diagnosis is made. [14] To ...

A2 Bio is currently conducting two seamless phase 1/2 clinical studies: EVEREST-1 studying A2B530 for pancreatic, lung and colorectal cancers by targeting carcinoembryonic antigen (CEA); and ...